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only one cGMP policy was required since GMP users had
their own program SOP. However, GMP users would be
trained in QM policies besides their own P/P. Our current
SOPM has 70 P/P, 81 forms & 3 presentations, covering all
areas of processing and is compliant with R/AA.
Conclusion: Our rationale for standardizing SOPM is based
speciﬁcally on 21 CFR Part 1271 which governs all CPLs and is
mandatory law. With standardization, we will have clarity,
identical training for staff, and assurance of adherence to
similar methodology as required by law, resulting in
consistency, uniformity, legitimacy and safety in our labo-
ratory manufactured products.P/P Title Sub Titles Forms
I. Q M
1. Quality Assurance Organization; Terminology
2. Good Manufacturing
3. Responsibilities Lab Tech to MD
4. Security & Safety Safety manual etc 2
5. Utility Mgmt Air Handling; Compressor; etc 12
6. Training Training; Competency; CE 2
7. S.O.P. Mgmt Writing; Controls 5
8. Systems Controls; Validation 5
9. Event Mgmt 2
10. Audit 1
11. Equipment Mgmt BSC; Incubator etc; PM etc 7
12. Accreditation Mgmt 5
13. Supplies 2
14. E M Mgmt 4
15. Cleaning, Sanitization 2
16. Data Mgmt Documentation; Billing
II. Processing
1. HCT/P Quality Assurance Donor, Patient, Product 3
2. Quality Testing 1
3. Chain of Custody 3
4. HCT/P Manufacturing From Receipt to Infusion 20
5. Data Mgmt
6. Equipment Ops Cobe 2991; Cell Counter etc 5
III. cGMP
1. Gowning334
Substantial Variation in Medicaid Coverage for
Hematopoietic Cell Transplantation
Jaime M. Preussler 1, Stephanie Farnia 2, Ellen Denzen 3,
Navneet S. Majhail 2. 1 Patient Services, Natoinal Marrow
Donor Program, Minneapolis, MN; 2National Marrow Donor
Program, Minneapolis, MN; 3 Patient Services, National
Marrow Donor Program (NMDP)
Medicaid is a jointly funded federal-state program that
provides payment for health services for pregnant women,
children, parents, seniors and disabled individuals. States
establish and administer their own Medicaid programs and
determine the type, amount, and scope of services within
federal guidelines which mandate coverage of certain
beneﬁts. Optional beneﬁts that can be provided by the state
can lead to a wide variation of beneﬁts offered. Hemato-
poietic cell transplant (HCT) is not a mandatory covered
service for adults, and each state has the discretion to
choose whether to cover it and the extent of the coverage.
Variation in state policies can impact access to care for
patients. At the same time, many patients rely on Medicaid
for HCT coverage e according to HCUPnet data, Medicaid
paid for 3,064 HCT hospitalizations (16% of HCT discharges)
in the US in 2010. A national comparison of Medicaid
coverage for HCT was undertaken to learn more about statevariation. Information on HCT coverage beneﬁts for 2012
was collected from state Medicaid websites and was
compared to the recommendations for minimum beneﬁts
that have been developed by the National Marrow Donor
Program in collaboration with physicians, transplant
centers and payors (www.marrow.org/payor). Data was
coded on a three point scale depending on whether indi-
vidual state coverage met minimum beneﬁts criteria (score
2), provided some but not minimum beneﬁts (score 1), or
did not provide any beneﬁts (score 0) for the following 5
categories: 1) transplant procedure and disease indications,
2) donor search, 3) medications, 4) clinical trials, and 5)
patient food, lodging and transportation. Data were avail-
able for 47 states (Figure 1). No state provided minimum
coverage beneﬁts in all 5 categories and only three states
met the minimum in 4/5 categories. Our study highlights
substantial variation in Medicaid coverage by state for HCT
which may serve as a barrier to access to HCT for some
patients. In light of the Affordable Care Act and the deter-
mination of Essential Beneﬁts by individual states,
a common framework for complex medical procedures
such as HCT may be beneﬁcial.
Figure 1.
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The Beneﬁts of Metadata Analysis and Form Question
Harmonization
Sandra Sorensen, Robinette Renner. CIBMTR - IT, National
Marrow Donor Program, Minneapolis, MN
Background: In order to collect high-quality data from
multiple organizations, there must be a clear understanding
as to what data is needed and how it is to be reported.
Metadata, often described as “data about data,” describes
the content, quality, and other attributes of the data being
collected. These attributes include maximum length,
number of decimal places, data type (character, number, or
date), multiple choice answer vs. free text, etc. Historically,
FormsNet (FN), the Center for International Blood and
Transplant Research's (CIBMTR) electronic data capture
system, stored the metadata at the question level. Since
data collection forms were created independently, differ-
ences in question design and metadata became problem-
atic. For example, primary disease is a list of valid values on
one form and free text on another. In an effort to improve
data quality and facilitate analysis, the use of well-deﬁned
metadata and data standards, took on a more prominent
role.
Methods: Common data elements (CDE) were created using
the National Cancer Institute's Cancer Data Standards
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Element Concept describes the form question and the Value
Domain describes how the answer should be reported. Each
CDE contains the metadata required for a form question.
Questions requiring the same metadata are represented by
a common CDE. In addition, the metadata in FN was moved
from the question level to a cross-form data dictionary and
linked to CDEs to further standardize the required data and
its format.
Results: A review of the current baseline and follow-up
forms indicates that harmonizing the data dictionary entries
(DDC) with the CDEs has led to an approximately 25%
reduction (583 DDCs and 437 CDEs) in the number of data
points being deﬁned multiple times. This has led to more
consistent forms and data collection.
Conclusion: The CIBMTR's data collection forms include
questions that are asked multiple times within and across
forms. To facilitate data entry and analysis, form inconsis-
tencies needed to be addressed. To help alleviate these
issues, the data dictionary entry and metadata are tied to
a CDE. In addition, a metadata review is now undertaken at
each step in the form revision/development process to
ensure questions are harmonized, terminology is used
consistently, question formats are standardized, and the
option values are semantically similar. Exceptions are only
allowed when clinical differences and regulatory compli-
ance dictate. The beneﬁts of using well-deﬁned metadata
and data standards include unambiguous interpretation of
data points, improved data exchange, facilitated data anal-
ysis, improved cross-form consistency, and the creation of
a pool of data elements to be used for new form develop-
ment.
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Transplant: The Ultimate Team Sport. A Potential Answer
to Workforce Challenges in Hematopoietic Stem Cell
Transplant
Jeffrey Schriber 1, Virginia G. Piper 1, Adrienne Briggs 2,
Selma Kendrick 2. 1 Cancer Center, Cancer Transplant Institute
Scottsdale Health Care, Scottsdale, AZ; 2 Cancer Transplant
Institute Scottsdale Health Care, Scottsdale, AZ
A major challenge for transplanters, is how to meet the
workforce capacity necessary to support the increase in
transplants that are projected. This includes physicians,
nurses, NP's and PA's, pharmacists, coordinators, social
workers and many others who make up the transplant
team. Despite the extensive hours often required, repeatedly
when staff are asked what they enjoy most about transplant
the word team comes up. In the summer of 2011 a clinically
successful transplant program in Phoenix Arizona was
closed due to a change in values at the parent institution.
The transplant team wanted to continue to serve current
and future transplant patients. After discussion with FACT it
was recognized to maintain accreditation that all key
personal or the “blood and guts” of the program must move
together. In November 2011 the team moved to a new
facility. Transplant SOP's and Quality manuals were
completely rewritten. Follow up of existing patients began
immediately, new patients were seen starting in January, an
inpatient and outpatient unit was rebuilt and certiﬁed bythe state in February and the ﬁrst transplant was performed
that month. At present the following have been performed.
250 Consults from 74 different providers 67 Apheresis
Procedures 50 Transplants (29 Auto, 12 Sibling, 9 MUD) 4
Insurance company inspections 1 FACT Inspection During
this time staff frequently worked overtime and yet their
overall satisfaction scores went from 2.3 to 9.4. When asked
to state the best thing about what they did the answer was
virtually unanimous; the team approach. This approach
increases satisfaction for the transplant team who often
experience signiﬁcant stress and pressure relative to the
patients that they encounter. Using a team collaborative
approach enhances feelings of accomplishment and
improves satisfaction scores. Such an approach may be
useful in dealing with the workforce challenges in the BMT
ﬁeld.337
Use of National Registry Demographic Data for Resource
Planning
Steven Tran, Leonie Wilcox. The Australasian Bone Marrow
Transplant Recipient Registry
Introduction: Australia's combination of a large land area
(7.7 million square km) and relatively small population (22.7
million) contributes to unique resource planning issues for
specialist services. The population density of Australia is 2.9
people per square km, compared with 32.7 in the USA,
256.3 in the United Kingdom and 337.4 in Japan. Despite
high urbanisation in Australia, many patients need to travel
long distances for treatment, particularly those receiving
allogeneic transplants. In 2011, 498 allogeneic transplants
were performed in Australia. With increasing post trans-
plant survival and recognition of the long term follow-up
needs of survivors, it is important to optimise the use of
resources so that all patients have access to appropriate
care.
Methods: Residential postcodes were available for 3,655 of
the 4041 patients who received allogeneic transplants in
Australia from 2002-2011 (90%). These postcodes were
extracted from the ABMTRR database and converted via
geocoding into latitude and longitude for display onto
a map. This same method was used to obtain a location for
the transplant centres. Distances from the residential post-
codes to the transplant centres were calculated and
analysed.
Results: The median distance travelled for allogeneic trans-
plant patients in Australia was 25.7 km (range 0.1 km - 3,155
km). Thirty nine percent of patients travelled more than 50
km to their transplant centre, with 28% travelling more than
100 km and 6% travelling more than 500 km. On average,
patients travelled longer distances to paediatric centres than
adult centres.
Conclusions: Visualisation of referral patterns on maps and
analysis of the distances between residential addresses and
transplant centres are useful tools for developing follow-up
protocols. It is anticipated that e-health services will become
an important aspect of the long term care of transplant
patients, and will be especially beneﬁcial for patients in
remote areas.
